Etoposide shows an identical outcome to bevacizumab monotherapy, but etoposide displays higher toxicity.61, 62, 63Additional VEGF such as cediranib has demonstrated meaningful potency in phase II clinical research of recurrent glioblastoma. Here, VEGFA is linked to glioblastoma.